Saturday, 31 October 2026European Markets

EU semiconductor firms hit by US 10% tariff as chip stocks fall 3-4% despite Nvidia earnings beat

ASML dropped 4% on February 26, 2026, alongside Applied Materials (-4%), AMD (-3%), and Broadcom (-3%), after US 10% global tariffs took effect February 23. European chipmakers face supply chain cost pressures despite strong Q4 earnings from Nvidia, raising questions about EU regulatory response to protect its €50B semiconductor industry.

EU semiconductor firms hit by US 10% tariff as chip stocks fall 3-4% despite Nvidia earnings beat
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

ASML Holding fell 4% on February 26, 2026, leading declines across European and US semiconductor stocks after Washington's 10% global tariff went into effect three days earlier. Applied Materials dropped 4%, while AMD and Broadcom declined 3% each, despite Nvidia posting strong Q4 2025 earnings that would typically lift the sector.

The tariffs hit Europe's semiconductor manufacturers at a critical moment. ASML supplies extreme ultraviolet lithography machines essential for advanced chip production, with 40% of revenue from Asian markets now facing higher import costs. STMicroelectronics and Infineon Technologies also rely on trans-Atlantic supply chains vulnerable to tariff disruption.

Brussels has not announced countermeasures, but European Commission officials are reviewing options under the EU Chips Act. The 2023 legislation allocated €43B to boost domestic semiconductor production to 20% of global capacity by 2030, up from 9% currently. Industry groups warn tariffs could delay these timelines by raising equipment costs 8-12%.

Analyst estimates show European chip firms face €2-4B in additional annual costs if tariffs persist through 2027. ASML's machines cost €150-200M each; a 10% tariff adds €15-20M per unit. Smaller firms like Nordic Semiconductor and Dialog Semiconductor lack pricing power to pass costs to customers, threatening margins already compressed by China's economic slowdown.

The sell-off contradicts fundamentals. Nvidia reported $22.1B Q4 revenue, up 265% year-over-year, driven by AI data center demand that benefits European suppliers. Analysts expected chip stocks to rally 5-7% post-earnings. Instead, tariff concerns triggered concentrated selling.

EU trade officials meet March 15 to discuss semiconductor tariff impacts. Options include WTO dispute proceedings, reciprocal tariffs on US tech imports, or accelerated subsidies for European fabs. Germany's economy ministry proposed €8B in emergency funding for domestic chip production, pending Bundestag approval.

Investor focus now shifts to March earnings calls from ASML and STMicroelectronics, where executives will quantify tariff impacts on 2026 guidance. Semiconductor stocks remain 12% below January peaks, underperforming the Stoxx Europe 600 by 8 percentage points since tariff implementation.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com